Simplex Trading, LLC Acorda Therapeutics Inc Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.55 - $1.0 $5,337 - $9,704	-9,704 Reduced 38.63%	15,416 $9,000
Q4 2022 Feb 02, 2023	BUY	$0.52 - $0.77 $9,471 - $14,025	18,215 Added 263.79%	25,120 $19,000
Q3 2022 Nov 04, 2022	SELL	$0.29 - $0.53 $279 - $511	-965 Reduced 12.26%	6,905 $2,000
Q2 2022 Aug 03, 2022	BUY	$0.3 - $1.67 $653 - $3,637	2,178 Added 38.26%	7,870 $3,000
Q1 2022 May 02, 2022	SELL	$1.61 - $2.5 $5,958 - $9,252	-3,701 Reduced 39.4%	5,692 $9,000
Q4 2021 Feb 23, 2022	BUY	$2.3 - $4.71 $21,603 - $44,241	9,393 New	9,393 $22,000
Q2 2021 Aug 12, 2021	SELL	$3.61 - $5.23 $20,013 - $28,995	-5,544 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$3.8 - $8.04 $21,067 - $44,573	5,544 New	5,544 $26,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.